Delivery Order SPE2DB24D2212-SPE2DB25FHQUE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, with an ultimate completion date of September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order transaction under AmerisourceBergen's larger federal contract portfolio with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader federal contracting relationship with the agency. This...
- The Defense Logistics Agency issued a delivery order for NEMLUVIO 30 mg pens valued at $3,858.40 to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award, made on August 25, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement. Performance will take place at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 9, 2025, with completion targeted for September 30, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 8, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...
- The U.S. Department of Defense's Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 2, 2025, with completion targeted for September 23, 2025. This firm fixed-price contract, which was competitively awarded without set-aside restrictions, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens with an ultimate completion date of October 1, 2025. This competitive award, issued on September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under contract 4569086102. This firm fixed price delivery order, issued on August 13, 2025, is part of a larger indefinite delivery contract (IDC) vehicle and represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQUEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, with performance in Conshohocken, Pennsylvania and completion by October 2, 2025. This competitive award, issued September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The contract supports customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement mechanism aligned with the DLA's pharmaceutical supply strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/11/25 |